Tools and Overview Tables

SWG Tools and Overview Tables of 2021-2022 calendar years

Continuation of EPICOVIDEHA survey: COVID-19 infections in patients with Hematological Malignancies. Principal investigator: Livio Pagano; Alternative principal investigator: Oliver A. Cornely; Project manager: Jon Salmanton-García; Research associate: Francesco Marchesi

EHA Congress 2022

  1. SWG Session at EHA27 | Guidelines Session: EHA Guidelines on Antifungal prophylaxis and therapy in patients with AML treated with new agents. Chair: Unknown
    Jannik Stemler (DE) – Overview of guidelines
  2. SWG Session at EHA27 | Scientific Working Group Session: Infections in hematology: Prevention and treatment of infections in hematology - An update. Chair: Unknown
    Jannik Stemler (DE) - AML and Therapeutic Drug Monitoring (TDM) - Antifungals and novel AML agents

EHA Congress 2021

SWG Session at EHA26 | Infections in hematology: The critically ill patient during the pandemic. Chair: Oliver Cornely (DE)

  • Russel Edward Lewis (IT) - Pharmacokinetic considerations of anti-infective drugs in the ICU: Drug-drug interactions, ECMO, Renal Replacement Therapy
  • Martin Hoenigl (AT) - Fungal superinfections complicating severe COVID-19 in the ICU
  • Philipp Koehler (DE) - ICU admission of hematological patients during the pandemic: Who to admit and what’s the prognosis?
  • Livio Pagano (IT) - EPICOVIDEHA survey. COVID-19 infections in patients with hematological malignancies. Results from EHA-IDWP registry

 Continuation of EQUAL Score Cards in cooperation with the European Confederation of Medical Mycology (ECMM)

Aspergillus | +3 languages

  • Danish: 10.4126/FRL01-006430393
  • Japanese: 10.4126/FRL01-006399677
  • Korean: 10.4126/FRL01-006433694

Candida | +2 languages

  • Japanese: 10.4126/FRL01-006399448
  • Korean: 10.4126/FRL01-006433695

 Cryptococcus | +2 languages

  • Japanese: 10.4126/FRL01-006399677
  • Korean: 10.4126/FRL01-006433694

Mucorales | +3 languages

  • Danish: 10.4126/FRL01-006430392
  • Korean: 10.4126/FRL01-006399449
  • Japanese: 10.4126/FRL01-006433697

Scedosporium | +1 infection; +18 languages

  • Azerbaijani: 10.4126/FRL01-006406925
  • Chinese: 10.4126/FRL01-006431386
  • Croatian: 10.4126/FRL01-006432038
  • Czech: 10.4126/FRL01-006399390
  • Dutch: 10.4126/FRL01-006431385
  • Greek: 10.4126/FRL01-006400993
  • Hungarian: 10.4126/FRL01-006430117
  • Italian: 10.4126/FRL01-006401914
  • Japanese: 10.4126/FRL01-006404772
  • Korean: 10.4126/FRL01-006433698
  • Kurdish: 10.4126/FRL01-006431383
  • Portuguese: 10.4126/FRL01-006432034
  • Romanian: 10.4126/FRL01-006402629
  • Russian: 10.4126/FRL01-006430116
  • Serbian: 10.4126/FRL01-006432039
  • Spanish: 10.4126/FRL01-006430115
  • Swedish: 10.4126/FRL01-006432035
  • Turkish: 10.4126/FRL01-006430332

Trichosporon | +1 infection; +3 languages

  • English: 10.4126/FRL01-006434017
  • German: 10.4126/FRL01-006434093
  • Japanese: 10.4126/FRL01-006402628

EHA Guideline Project

Publication of the Guideline: Antifungal prophylaxis in acute myeloid leukaemia treated with novel targeted therapies: Stemler J, de Jonge N, Skoetz N, Sinkó J, Brüggemann RJ, Busca A, Ben-Ami R, Ráčil Z, Piechotta V, Lewis R, Cornely OA. Antifungal prophylaxis in adult patients with acute myeloid leukaemia treated with novel targeted therapies: a systematic review and expert consensus recommendation from the European Hematology Association. Lancet Haematol. 2022 May;9(5):e361-e373. doi: 10.1016/S2352-3026(22)00073-4. Erratum in: Lancet Haematol. 2022 Jun;9(6):e398. PMID: 35483397.


Since the initiation of SWG on Infections in Hematology in 2017, 183 members from 25 countries have joined the group.

The SWG aims at building a clinical trial network on infection in hematology. Thus, all members of the SWG got access to the SiteManagementSystem (

The SWG has uploaded several clinical tool and guidance documents to its EHA SWG website.

Tools and overview tables for infectious diseases management

  1. Treatment standard in febrile neutropenia, UKK
  2. Galactomannan testing for invasive aspergillosis
  3. Protocol for Investigation and Management of IFI in Haematology Patients (Cardiff and Vale University Health Board)
  4. Available guidelines on infections in hematology
  5. Mucor Emergency Procedure Standard Card
  6. Equal Score Cards for the management of invasive fungal infections

    A) Aspergillosis

E) Scedosporiosis/Lomentosporiosis

F) Trichosporon